New Key Statistics Module, Z-Score and F-Score
NAS:VRAX Key Ratios
Market Cap $ M | 2.88 |
Enterprise Value $ M | -2.04 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.35 |
Price/Sales | 2.80 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -18.98 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.30 |
EV-to-EBITDA | 0.30 |
PEG | -- |
Shares Outstanding M | 2.36 |
Net Margin (%) | -8,655.00 |
Operating Margin % | -8,747.50 |
Pre-tax Margin (%) | -8,647.50 |
Quick Ratio | 7.56 |
Current Ratio | 7.59 |
ROA % (ttm) | -93.84 |
ROE % (ttm) | -104.63 |
ROIC % (ttm) | -820.72 |
Dividend Yield % | -- |
Altman Z-Score | -0.54 |
VRAX Number of Guru Trades
VRAX Volume of Guru Trades
Gurus Latest Trades with NAS:VRAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRAX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Virax Biolabs Group Ltd Insider Transactions
No Available Data
News about NAS:VRAX
Total 0- 1